ICG Fluorescence Imaging in Open Fracture Trauma Patients

Active, not recruitingOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Trauma Injury
Interventions
OTHER

Immunofluorescence Imaging

Patients will be administered FDA approved ICG through intravenous injection and imaged by a FDA approved surgical microscope (Spy Elite) which is 0.5 meter away from the subject. Both ICG fluorescence and the two imaging systems have been used for routine clinical practice for many years. Figure (a) shows the Schematic sketch of the imaging systems. ICG fluorescence imaging utilizes intravenously injected ICG, which is a fluorescent dye that is FDA-approved for clinical use, illuminated with near-infrared light. The ICG dye is indirectly activated and the dynamic fluorescence due to bone perfusion can be captured by a video rate imaging system.

Trial Locations (4)

21201

University of Maryland, Baltimore R. Cowley Shock Trauma, Baltimore

92614

University of California, Irvine, Irvine

021115

Brigham and Women's Hospital, Boston

03756

Dartmouth Hitchcock Medical Center, Lebanon

All Listed Sponsors
collaborator

Dartmouth College

OTHER

collaborator

United States Department of Defense

FED

collaborator

Brigham and Women's Hospital

OTHER

collaborator

University of California, Irvine

OTHER

collaborator

University of Maryland, Baltimore

OTHER

lead

Dartmouth-Hitchcock Medical Center

OTHER